Cargando…

Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities’ daily life, and the University...

Descripción completa

Detalles Bibliográficos
Autores principales: Videla, Sebastián, Otero, Aurema, Martí, Sara, Domínguez, M. Ángeles, Fabrellas, Nuria, Delgado-Hito, M. Pilar, Cruz, Imma, Tebé, Cristian, Vinuesa, Teresa, Ardila, Fernando, Sancho, Marta, Fernández, Esteve, Figuerola, Montserrat, Ciruela, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296357/
https://www.ncbi.nlm.nih.gov/pubmed/34204383
http://dx.doi.org/10.3390/ijerph18126526
_version_ 1783725619856539648
author Videla, Sebastián
Otero, Aurema
Martí, Sara
Domínguez, M. Ángeles
Fabrellas, Nuria
Delgado-Hito, M. Pilar
Cruz, Imma
Tebé, Cristian
Vinuesa, Teresa
Ardila, Fernando
Sancho, Marta
Fernández, Esteve
Figuerola, Montserrat
Ciruela, Francisco
author_facet Videla, Sebastián
Otero, Aurema
Martí, Sara
Domínguez, M. Ángeles
Fabrellas, Nuria
Delgado-Hito, M. Pilar
Cruz, Imma
Tebé, Cristian
Vinuesa, Teresa
Ardila, Fernando
Sancho, Marta
Fernández, Esteve
Figuerola, Montserrat
Ciruela, Francisco
author_sort Videla, Sebastián
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities’ daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed a cross-sectional study on a sample of 2784 UB members (n = 52,529). Participants answered a brief, ad hoc, online epidemiological questionnaire and provided a nasal swab for reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 analysis and a venous blood sample for SARS-CoV-2 IgG antibody assay. Total prevalence of SARS-CoV-2 infection (positive RT-PCR or positive IgG) was 14.9% (95%CI 13.3 to 17.0%). Forty-four participants (1.6%, 95%CI: 1.2–2.1%) were positive for SARS-CoV-2 RT-PCR. IgG against SARS-CoV-2 was observed in 12.8% (95%CI: 11.6–14.1%) of participants. Overall, while waiting for population vaccination and/or increased herd immunity, we should concentrate on identifying and isolating new cases and their contacts.
format Online
Article
Text
id pubmed-8296357
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82963572021-07-23 Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain Videla, Sebastián Otero, Aurema Martí, Sara Domínguez, M. Ángeles Fabrellas, Nuria Delgado-Hito, M. Pilar Cruz, Imma Tebé, Cristian Vinuesa, Teresa Ardila, Fernando Sancho, Marta Fernández, Esteve Figuerola, Montserrat Ciruela, Francisco Int J Environ Res Public Health Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities’ daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed a cross-sectional study on a sample of 2784 UB members (n = 52,529). Participants answered a brief, ad hoc, online epidemiological questionnaire and provided a nasal swab for reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 analysis and a venous blood sample for SARS-CoV-2 IgG antibody assay. Total prevalence of SARS-CoV-2 infection (positive RT-PCR or positive IgG) was 14.9% (95%CI 13.3 to 17.0%). Forty-four participants (1.6%, 95%CI: 1.2–2.1%) were positive for SARS-CoV-2 RT-PCR. IgG against SARS-CoV-2 was observed in 12.8% (95%CI: 11.6–14.1%) of participants. Overall, while waiting for population vaccination and/or increased herd immunity, we should concentrate on identifying and isolating new cases and their contacts. MDPI 2021-06-17 /pmc/articles/PMC8296357/ /pubmed/34204383 http://dx.doi.org/10.3390/ijerph18126526 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Videla, Sebastián
Otero, Aurema
Martí, Sara
Domínguez, M. Ángeles
Fabrellas, Nuria
Delgado-Hito, M. Pilar
Cruz, Imma
Tebé, Cristian
Vinuesa, Teresa
Ardila, Fernando
Sancho, Marta
Fernández, Esteve
Figuerola, Montserrat
Ciruela, Francisco
Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain
title Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain
title_full Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain
title_fullStr Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain
title_full_unstemmed Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain
title_short Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain
title_sort prevalence of sars-cov-2 infection at the university of barcelona during the third covid-19 pandemic wave in spain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296357/
https://www.ncbi.nlm.nih.gov/pubmed/34204383
http://dx.doi.org/10.3390/ijerph18126526
work_keys_str_mv AT videlasebastian prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT oteroaurema prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT martisara prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT dominguezmangeles prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT fabrellasnuria prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT delgadohitompilar prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT cruzimma prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT tebecristian prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT vinuesateresa prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT ardilafernando prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT sanchomarta prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT fernandezesteve prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT figuerolamontserrat prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain
AT ciruelafrancisco prevalenceofsarscov2infectionattheuniversityofbarcelonaduringthethirdcovid19pandemicwaveinspain